IKS03

· Iksuda Therapeutics Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IKS03, covering 2025-10-01 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas [Phase 1]